NovaBay Pharmaceuticals Inc is a biopharmaceutical company engaged in commercializing & developing non-antibiotic anti-infective products to address the unmet therapeutic needs of the eye care market. Its product categories include NEUTROX & CELLERX.
$2.27 -0.06 (-2.58%)
As of 02/08/2023 15:59:50 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.